Saint Francis University Partners with ASTRI on Targeted Drug Delivery and Degradable Implants
AM730 · 1 SOURCES43 minutes ago2 MIN
Summary
Saint Francis University and the Hong Kong Applied Science and Technology Research Institute (ASTRI) signed a memorandum of understanding on Wednesday to establish a strategic partnership, with President Cheung Yan-leung and CEO Sun Yiu-tat signing on behalf of their respective institutions . The agreement focuses on advancing artificial intelligence biomaterials and digital health technology R&D, with the goal of accelerating innovation, promoting technology transfer, and nurturing the next generation of applied science talent . The collaboration operates across three core pillars: joint R&D, technology transfer and commercialization, and talent development . Specific research projects include nano-biomaterial-based diagnostic and therapeutic solutions, such as targeted drug delivery systems, biosensing platforms, and degradable implants, integrated with AI algorithms for real-time patient monitoring and personalized treatment adjustments . Beyond biomedical applications, the partnership will extend to digital health, elderly care, special educational needs (SEN) support, smart city applications, and educational technology solutions .
Key Points
- The partnership establishes three pillars: joint R&D, technology transfer/commercialization, and talent development
- Research will develop AI-driven biomaterial design platforms combining machine learning with materials science
- Nano-biomaterial applications include targeted drug delivery systems, biosensing platforms, and degradable implants
- Commercialization pathways include technology licensing, industry partnerships, and potential spin-off companies
- Student internship programs at ASTRI and joint academic-industry events will foster talent exchange
Why It Matters
The partnership leverages Saint Francis University's position as Hong Kong's largest registered nurse training institution alongside ASTRI's applied research capabilities, positioning Hong Kong to advance its goal of becoming an international innovation and technology hub . By targeting both the Greater Bay Area healthcare market and emerging Gulf Cooperation Council medical technology sectors, the collaboration opens significant commercial pathways for Hong Kong-developed medical innovations .
The partnership leverages Saint Francis University's position as Hong Kong's largest registered nurse training institution alongside ASTRI's applied research capabilities, positioning Hong Kong to advance its goal of becoming an international innovation and technology hub . By targeting both the Greater Bay Area healthcare market and emerging Gulf Cooperation Council medical technology sectors, the collaboration opens significant commercial pathways for Hong Kong-developed medical innovations .